| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0005492> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0005821> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0006904> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0014261> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0025962> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0032081> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0072642> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C0596577> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C4283948> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33045354_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Horphag Research, Geneva, Switzerland. Electronic address: Franziska.Weichmann@horphag.com.\', \'Institute of Pharmaceutical Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Rohdewald_Peter> <https://research.tib.eu/covid-19/entity/Weichmann_Franziska>
?:doi	<https://research.tib.eu/covid-19/entity/S0924-8579%2820%2930397-610.1016/j.ijantimicag.2020.106191>
?:doi	S0924-8579(20)30397-610.1016/j.ijantimicag.2020.106191
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	International journal of antimicrobial agents
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33045354>
?:pmid	<https://research.tib.eu/covid-19/entity/33045354>
?:pmid	33045354
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.699
?:rankingScore_hIndex	107
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C1825598_CAUSES_C0021368>
?:title	Projected supportive effects of PycnogenolⓇ in patients suffering from multi-dimensional health impairments after a SARS-CoV2 infection.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33045354>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33045354>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all